Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €74.46 | €102.62 | 37.818% |
| Exact Sciences | 13 | 0 | 2 | 0 | €51.01 | €82.63 | 61.989% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €286.60 | €297.31 | 3.738% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.38 | €174.43 | 16.772% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.60 | €130.00 | 6.036% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €698.60 | €760.00 | 8.789% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.00 | €116.81 | 20.420% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 4 | 0 | €910.00 | €957.22 | 5.189% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €208.00 | €294.01 | 41.351% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €157.26 | €200.06 | 27.214% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €140.32 | €196.74 | 40.205% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.80 | €124.93 | 4.281% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.66 | €86.77 | 38.479% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €53.50 | €78.42 | 46.584% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €397.95 | €408.36 | 2.615% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.83 | €15.58 | -1.560% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.36 | €40.66 | 54.276% |